Skip to main content
OpenTrials

Clinical trial condition

Hemostatic Disorders

Explore clinical trials studying Hemostatic Disorders. Study availability and eligibility vary by location and protocol.

3,075 public trials 581 recruiting studies
Refine in advanced search Browse all conditions

Hemostatic Disorders trial results

Completed

IFM2009-02-Pomalidomide and Dexamethasone Phase 2 Myeloma

NCT01053949

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • CHRU-Hôpital Sud, avenue Laennec, Amiens, France
  • Hématologie, Hôpital Avicenne Bobigny, France
  • Hématologie, CHU, avenue G.Clemenceau Caen, France
  • Hématologie Clinique, CHU, Hôpital d'Enfants Dijon, France
View all 19 locations
View Trial Details
Completed

ACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies

NCT02362035

Conditions
Blood Protein Disorders, Burkitt Lymphoma, CLL, +47 more
Locations
  • Research Site Tucson, Arizona, United States
  • Research Site Los Angeles, California, United States
  • Research Site Denver, Colorado, United States
  • Research Site Washington D.C., District of Columbia, United States
View all 19 locations
View Trial Details
Completed

Safety and Efficacy of ALLO-715 BCMA Allogenic CAR T Cells in in Adults With Relapsed or Refractory Multiple Myeloma (UNIVERSAL)

NCT04093596

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • City of Hope Duarte, California, United States
  • Stanford Cancer Institute Palo Alto, California, United States
  • Sarah Cannon/Colorado Blood Cancer Institute Denver, Colorado, United States
View Trial Details
Completed

IV Busulfan Plus Bortezomib Conditioning Regimen for Second Autologous Stem Cell Transplant in Multiple Myeloma Patients

NCT01009840

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Arizona Cancer Center Tucson, Arizona, United States
  • Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States
  • Loyola University Medical Center Maywood, Illinois, United States
  • Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States
View all 13 locations
View Trial Details
Completed

COM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies

NCT04354246

Conditions
Adnexal Diseases, Advanced Cancer, Blood Protein Disorders, +53 more
Locations
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Massachusetts General Hospital. Boston, Massachusetts, United States
  • START Midwest. Grand Rapids, Michigan, United States
  • The Ohio State University Comprehensive Cancer Center. Columbus, Ohio, United States
View Trial Details
Completed

Study to Evaluate Safety Tolerability & Efficacy of Kyprolis (Carfilzomib) in Relapsed or Refractory Multiple Myeloma

NCT03934684

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Yashoda Hospital Hyderabad, Andhra Pradesh, India
  • Apollo Hospital Hyderabad, Andhra Pradesh, India
  • M S Ramaiah Memorial Hospital Bangalore, Karnataka, India
  • K L E S Dr Prabhakar Kore Hospital and Medical Research Centre Belagavi, Karnataka, India
View all 17 locations
View Trial Details

Related conditions